Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies. 2023

Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA. sraghu2@emory.edu.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069594 Abatacept A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. BMS 188667,BMS-188667,BMS-224818,BMS224818,Belatacept,CTLA-4-Ig,CTLA4-Fc,CTLA4-Ig,CTLA4-Ig Immunoconjugate,Cytotoxic T Lymphocyte-Associated Antigen 4-Immunoglobulin,LEA29Y,Nulojix,Orencia,BMS 224818,BMS188667,CTLA4 Ig Immunoconjugate,Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin,Immunoconjugate, CTLA4-Ig
D061349 Unrelated Donors Providers of tissues for transplant to non-related individuals. Donors, Unrelated,Donor, Unrelated,Unrelated Donor
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell
D019172 Transplantation Conditioning Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation. Conditioning, Transplantation,Conditionings, Transplantation,Transplantation Conditionings
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
September 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
May 2016, British journal of haematology,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
June 2007, Transplantation proceedings,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
September 2003, Blood,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
July 2021, Transplantation and cellular therapy,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
December 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
March 2024, Blood cancer journal,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
August 1998, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
February 1995, Bone marrow transplantation,
Sharmila Raghunandan, and Muna Qayed, and Ben K Watkins, and Michael Graiser, and Lev Gorfinkel, and Adrianna Westbrook, and Scott Gillespie, and Brandi Bratrude, and Aleksandra Petrovic, and Yvonne Suessmuth, and John Horan, and Leslie S Kean, and Amelia A Langston
June 1999, Bone marrow transplantation,
Copied contents to your clipboard!